243 related articles for article (PubMed ID: 14702108)
21. Artificial antigen-presenting cells plus IL-15 and IL-21 efficiently induce melanoma-specific cytotoxic CD8+ CD28+ T lymphocyte responses.
Yu X; He J; Mongkhoune S; Peng Y; Xie Y; Su J; Zhou SF; Xie XX; Luo GR; Fang Y; Li X; Li X; Zhou N; Zhao YX; Lu XL
Asian Pac J Trop Med; 2013 Jun; 6(6):467-72. PubMed ID: 23711708
[TBL] [Abstract][Full Text] [Related]
22. Specific killing of cytotoxic T cells and antigen-presenting cells by CD4+ cytotoxic T cell clones. A novel potentially immunoregulatory T-T cell interaction in man.
Ottenhoff TH; Mutis T
J Exp Med; 1990 Jun; 171(6):2011-24. PubMed ID: 1972178
[TBL] [Abstract][Full Text] [Related]
23. Class I- and class II-reactive TCRs coexpressed on CD4+ T cells both trigger CD4/CD8-shared and CD4-unique functions.
Asnagli H; Schmitt-Verhulst AM; Guimezanes A
J Immunol; 1997 May; 158(10):4533-42. PubMed ID: 9144464
[TBL] [Abstract][Full Text] [Related]
24. Antigen organization regulates cluster formation and induction of cytotoxic T lymphocytes by helper T cell subsets.
Stuhler G; Schlossman SF
Proc Natl Acad Sci U S A; 1997 Jan; 94(2):622-7. PubMed ID: 9012834
[TBL] [Abstract][Full Text] [Related]
25. The fate of low affinity tumor-specific CD8+ T cells in tumor-bearing mice.
Lyman MA; Nugent CT; Marquardt KL; Biggs JA; Pamer EG; Sherman LA
J Immunol; 2005 Mar; 174(5):2563-72. PubMed ID: 15728462
[TBL] [Abstract][Full Text] [Related]
26. Clustering of T cell ligands on artificial APC membranes influences T cell activation and protein kinase C theta translocation to the T cell plasma membrane.
Giannoni F; Barnett J; Bi K; Samodal R; Lanza P; Marchese P; Billetta R; Vita R; Klein MR; Prakken B; Kwok WW; Sercarz E; Altman A; Albani S
J Immunol; 2005 Mar; 174(6):3204-11. PubMed ID: 15749850
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus-transformed B-cells as efficient antigen presenting cells to propagate Aspergillus-specific cytotoxic T-lymphocytes.
Ramadan G
Egypt J Immunol; 2008; 15(1):145-57. PubMed ID: 20306679
[TBL] [Abstract][Full Text] [Related]
28. CTLs target Th cells that acquire bystander MHC class I-peptide complex from APCs.
Cox JH; McMichael AJ; Screaton GR; Xu XN
J Immunol; 2007 Jul; 179(2):830-6. PubMed ID: 17617573
[TBL] [Abstract][Full Text] [Related]
29. Conditioned dendritic cells as a temporal bridge between T helper and cytotoxic cells.
Hall BM; Chen J; Robinson C; He XY; Plain K; Verma N; Hodgkinson ST
Transplant Proc; 2001; 33(1-2):195-6. PubMed ID: 11266776
[No Abstract] [Full Text] [Related]
30. BCR-ABL-specific CD4
Ueda N; Zhang R; Tatsumi M; Liu TY; Kitayama S; Yasui Y; Sugai S; Iwama T; Senju S; Okada S; Nakatsura T; Kuzushima K; Kiyoi H; Naoe T; Kaneko S; Uemura Y
Cell Mol Immunol; 2018 Jan; 15(1):15-26. PubMed ID: 27181332
[TBL] [Abstract][Full Text] [Related]
31. Formation of supramolecular activation clusters on fresh ex vivo CD8+ T cells after engagement of the T cell antigen receptor and CD8 by antigen-presenting cells.
Potter TA; Grebe K; Freiberg B; Kupfer A
Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12624-9. PubMed ID: 11606747
[TBL] [Abstract][Full Text] [Related]
32. Archaeosomes induce long-term CD8+ cytotoxic T cell response to entrapped soluble protein by the exogenous cytosolic pathway, in the absence of CD4+ T cell help.
Krishnan L; Sad S; Patel GB; Sprott GD
J Immunol; 2000 Nov; 165(9):5177-85. PubMed ID: 11046050
[TBL] [Abstract][Full Text] [Related]
33. CD40-CD40Ligand interactions and their role in cytotoxic T lymphocyte priming and anti-tumor immunity.
Toes RE; Schoenberger SP; van der Voort EI; Offringa R; Melief CJ
Semin Immunol; 1998 Dec; 10(6):443-8. PubMed ID: 9826577
[TBL] [Abstract][Full Text] [Related]
34. Programmed Death-Ligand 1 on Antigen-presenting Cells Facilitates the Induction of Antigen-specific Cytotoxic T Lymphocytes: Application to Adoptive T-Cell Immunotherapy.
Goto T; Nishida T; Takagi E; Miyao K; Koyama D; Sakemura R; Hanajiri R; Watanabe K; Imahashi N; Terakura S; Murata M; Kiyoi H
J Immunother; 2016 Oct; 39(8):306-15. PubMed ID: 27548033
[TBL] [Abstract][Full Text] [Related]
35. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
[TBL] [Abstract][Full Text] [Related]
36. Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB.
Maus MV; Thomas AK; Leonard DG; Allman D; Addya K; Schlienger K; Riley JL; June CH
Nat Biotechnol; 2002 Feb; 20(2):143-8. PubMed ID: 11821859
[TBL] [Abstract][Full Text] [Related]
37. T helper cells in cytotoxic T lymphocyte development: role of L3T4(+)-dependent and -independent T helper cell pathways in virus-specific and alloreactive cytotoxic T lymphocyte responses.
Ciavarra RP
Cell Immunol; 1990 Feb; 125(2):363-79. PubMed ID: 2153464
[TBL] [Abstract][Full Text] [Related]
38. Activation of CD8-dependent cytotoxic T lymphocyte adhesion and degranulation by peptide class I antigen complexes.
Kane KP; Mescher MF
J Immunol; 1993 Jun; 150(11):4788-97. PubMed ID: 8496589
[TBL] [Abstract][Full Text] [Related]
39. Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors.
Ossendorp F; Mengedé E; Camps M; Filius R; Melief CJ
J Exp Med; 1998 Mar; 187(5):693-702. PubMed ID: 9480979
[TBL] [Abstract][Full Text] [Related]
40. Presentation of native TROP-2 tumor antigens to human cytotoxic T lymphocytes by engineered antigen-presenting cells.
Mangino G; Grazia Capri M; Barnaba V; Alberti S
Int J Cancer; 2002 Oct; 101(4):353-9. PubMed ID: 12209960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
